Assoc. Prof. Nuri Alper Şahbaz is an experienced doctor with medical education from Istanbul University, Cerrahpaşa Faculty of Medicine, and scientific and clinical experience from Baylor College of Medicine and The University of Texas Medical School. He is specialized in endocrine surgery (thyroid, parathyroid, adrenal gland and neuroendocrine tumors) and has performed over 2000 successful surgeries in this area. He also specializes in laparoscopic and minimally invasive surgeries, as well as in diagnostic and therapeutic gastrointestinal system endoscopy.
Read moreDoctor's visit | price on request |
Radioiodine therapy | $4000 - $5000 |
Thyroidectomy | $5000 - $7500 |
Doctor's visit | price on request |
Radioiodine therapy | $4000 - $5000 |
Thyroidectomy | $5000 - $7500 |
Doctor's visit | price on request |
Radioiodine therapy | $4000 - $5000 |
Thyroidectomy | $5000 - $7500 |
Was born in 1981 in Erzincan. After finishing Beşiktaş Atatürk Anadolu High School in 1999 entered Istanbul University Çapa, Faculty of Medicine.
In 2005 I got his Master Degree and started as a practitioner at Yüksekova State Hospital. He got his Doctorate at Okmeydanı Training and Research Hospital in General Surgery department. As a General Surgery Specialist, he worked at Zonguldak Atatürk State Hospital for 5 years and at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for 3 years.
Worked as an Assistant Professor at Istanbul Medipol University, Department of General Surgery. Currently working at Medipol University Pendik Hospital.
Read moreEducation:
2021 ULUDAĞ ÜNİVERSİTESİ, KULAK BURUN BOĞAZ HASTALIKLARI
2014 EGE ÜNİVERSİTESİ, TIP FAKÜLTESİ
Experience:
2023 - 2023 SAĞLIK BİLİMLERİ ÜNİVERSİTESİ SULTAN ABDÜLHAMİD HAN EĞİTİM VE ARAŞTIRMA HASTANESİ
2021 - 2022 ŞEHİT PROF.DR. İLHAN VARANK SANCAKTEPE EĞİTİM VE ARAŞTIRMA HASTANESİ
Read moreEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Read moreEducation and Experience